Status:
COMPLETED
Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Primary Objectives: * To compare the severity of symptoms, their impact on affective and health-related functional status, and symptom interference among patients with advanced-stage lung cancer foll...
Detailed Description
One of the ways to learn about the symptoms of chemotherapy is by looking at how certain proteins called cytokines (found in the blood) change during therapy. Another way is to look at how symptoms ch...
Eligibility Criteria
Inclusion
- Is an adult \> 18 years of age
- Is diagnosed with Stage III or IV Lung cancer
- Is scheduled for a new chemotherapy regimen. Patients who have received prior chemotherapy are eligible.
- Is English- or Spanish-speaking
- Currently lives in the United States
Exclusion
- Does not have access to telephones
- Is unable to use the telephone interactive system
- Has a current diagnosis of psychosis or dementia
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT00422500
Start Date
November 1 2003
End Date
December 1 2010
Last Update
August 2 2012
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Jackson Memorial Hospital
Miami, Florida, United States, 33136
2
Lyndon Baines Johnson General Hospital
Houston, Texas, United States, 77026
3
Ben Taub General Hospital
Houston, Texas, United States, 77030
4
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030